Atlas Trials

Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients

Clinical trial NCT06273215 · UNKNOWN

Trial details

NCT number
NCT06273215
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes
Start date
2023-03-05
Primary completion
2025-12-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.